health care  
All about respiratory syncytial virus (RSV) infection causes of respiratory syncytial virus (RSV) infection signs and symptoms of RSV infection complications of RSV infection risk factors for RSV infection diagnosis of RSV infection treatment for RSV infection prevention of RSV infection

What is the treatment for RSV infection?

Most people with mild RSV infections usually get better without treatment. Care of patients with mild illness centers on relieving symptoms and easing breathing. Those with more serious infections are sometimes treated in the hospital with the anti-virus drug ribavirin. Some hospitalized patients need intensive care and mechanical ventilation (respirator). Children

with severe disease may require oxygen therapy and sometimes mechanical ventilation. Ribavirin aerosol may be used in the treatment of some patients with severe disease. Some investigators have used a combination of immune globulin intravenous (IGIV) with high titers of neutralizing RSV antibody (RSV-IGIV) and ribavirin to treat patients with compromised immune systems.

If an otherwise healthy baby develops cold symptoms, they usually will gradually resolve on their own within a week or two, regardless of whether they are caused by a cold or RSV. For mild RSV infection, measures to help relieve symptoms usually are all that is needed. Some babies with RSV infection may require hospitalization. When complications develop in otherwise healthy children, corticosteroid medications sometimes are used. However, more study is needed before corticosteroids are routinely recommended for this purpose. A child who is having difficulty breathing or is dehydrated may need to be cared for in a hospital. The child may need respiratory and other medical treatments. Very rarely, some children receive the antiviral medication ribavirin while they are in the hospital. Pregnant women should avoid contact with a child who is receiving ribavirin. If your child is in the hospital for RSV, there are extra measures you can take to make his or her stay comfortable.


More information on respiratory syncytial virus (RSV) infection

What is the respiratory syncytial virus (RSV)? - Respiratory syncytial virus (RSV) is a very common virus that causes mild cold-like symptoms in adults and older healthy children.
What causes respiratory syncytial virus (RSV) infection? - Respiratory syncytial virus, or RSV, is a virus that attacks the mucous membranes of people's respiratory tracts.
What're the signs and symptoms of RSV infection? - Signs and symptoms of respiratory syncytial virus (RSV) infection include stuffy nose, cough, and sometimes ear infection.
What complications can result from RSV infection? - A person with a first RSV infection can develop severe breathing problems that need to be managed in the hospital.
Who is at risk for RSV infection? - Very young infants, and children with underlying lung, heart, or immune system problems are at high risk for severe RSV disease.
How is RSV infection diagnosed? - Diagnosis of RSV infection can be made by virus isolation, detection of viral antigens, detection of viral RNA.
What is the treatment for RSV infection? - Most people with mild RSV infections get better without treatment. RSV antibody and ribavirin to treat patients with compromised immune systems.
How can RSV infection be prevented? - RSV transmission can and should be prevented by strict attention to contact precautions, such as hand washing and wearing gowns and gloves.
Respiratory & lung diseases Mainpage

Topics in respiratory and lung diseases

Lung diseases
Occupational lung diseases
Respiratory infections
Respiration disorders
Broncheal diseases
Pleural diseases
Lung transplant

Featured articles on respiratory and lung diseases

COPD (Chronic obstructive pulmonary disease)
Lung cancer
Pulmonary hypertension
Cystic fibrosis
Severe acute respiratory syndrome (SARS)

All information is intended for reference only. Please consult your physician for accurate medical advices and treatment. Copyright 2005,, all rights reserved. Last update: July 18, 2005